EP3842408A1 — Co-crystal of ketoprofen and its preparation, pharmaceutical compositions comprising the same and uses thereof
Assigned to Dompe Farmaceutici SpA · Expires 2021-06-30 · 5y expired
What this patent protects
The present invention refers to a co-crystal of Ketoprofen Lysine named Form 4, a pharmaceutical composition comprising said co-crystal, a process for its preparation and to its use in the treatment of pain and inflammatory diseases.
USPTO Abstract
The present invention refers to a co-crystal of Ketoprofen Lysine named Form 4, a pharmaceutical composition comprising said co-crystal, a process for its preparation and to its use in the treatment of pain and inflammatory diseases.
Drugs covered by this patent
- Celebrex (celecoxib) · Pfizer Inc. (originally Searle/Pharmacia)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.